The case for cognitive screening in HIV clinics

P McNamara1, J Redmond, C Bergin

  • 1Department of Neurology, Hospital 5 HCC, St. James's Hospital, Dublin 8. pmcnamara@stjames.ie

Irish Medical Journal
|September 27, 2012
PubMed
Summary

This study found that using surrogate markers identified cognitive impairment in 13.8% of HIV patients. These markers are less effective than structured screening for assessing cognitive function in people with HIV.